REGEN-COV antibody cocktail Is active against SARS-CoV-2 variants identified in the UK and South Africa
On Jan. 27, 2021, researchers in Dr. David Ho’s Columbia University lab and Regeneron scientists announced they had…
-
-
In vitro studies demonstrated COVID-19 vaccine elicited antibodies that neutralize SARS-CoV-2 with UK and South African Variants
On Jan. 27, 2021, Pfizer and BioNTech announced results from in vitro neutralization studies of sera from individuals…
-
Moderna COVID-19 vaccine retained neutralizing activity against emerging variants identified in UK and South Africa
On Jan. 25, 2021, Moderna announced results from in vitro neutralization studies of sera from individuals vaccinated with…
-
ImmunityBio simulations revealed why spreading South Africa strain of SARS-CoV-2 may escape existing immunity
On Jan. 19, 2021, ImmunityBio reported findings from a follow-up Molecular Dynamics simulation study of the SARS-CoV-2 spike…
-
ImmunityBio announced phase I trial of COVID-19 vaccine candidate in South Africa as new variants spread
On Jan. 19, 2021, ImmunityBio announced it had received authorization from the South Africa Health Products Regulatory Authority…
-
T2 Biosystems T2SARS-CoV-2 panel proved effective with global rise in variants of the SARS-CoV-2 virus
On Jan. 11, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detects…
-
COVISHIELD completed enrollment of phase III clinical trials under partnership of ICMR and Serum Institute
On Nov. 11, 2020, the Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) announced…
-
Global clinical trials of COVID-19 vaccine resumed
On Oct. 23, 2020, the U.S. FDA authorised a restart of clinical trials of the ChAdOx1 nCov-2019 Oxford…
-
FDA authorised restart of the COVID-19 AZD1222 vaccine US phase III trial
On Oct. 23, 2020, AstraZeneca announced that the clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, had…
-
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…
-
Novavax initiated efficacy trial of COVID-19 vaccine in South Africa
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
-
Illumina’s donation to Africa Centre for Disease Control expanded capability for sequencing-based COVID-19 surveillance
On Apr. 28, 2020, Illumina announced that the African Union Commission, on behalf of the Africa Center for…
-
Fred Hutch trial halted after promising HIV vaccine failed to show efficacy
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
-
The International Centre for Genetic Engineering and Biotechnology located Centres India and Italy
In 1984, the International Centre for Genetic Engineering and Biotechnology (ICGEB), the U.N. Industrial Development Organization (UNIDO) bowed…
-
Allan Cormack of Tufts University and Godfrey Hounsfield of EMI Laboratories were awarded the Nobel Prize in Physiology
In 1979, South African-born physicist Allan Cormack of Tufts University and British engineer Godfrey Hounsfield of EMI Laboratories…
-
The last naturally occurring case of smallpox in the world was diagnosed in Somalia
On Oct. 30, 1977, Ali Maow Maalin, a hospital cook in Merca, Somalia, was diagnosed with smallpox by…
-
Outbreak in South Africa raises possibility of wild birds as a possible reservoir for influenza A viruses
In 1961, influenza virus was first isolated from wild birds in South Africa, from common terns (Sterna hirundo)….
-
Johnson ﾠ&ﾠ Johnson established operations in Mexico and South Africa
In 1930, Johnsonﾠ&ﾠJohnson established operations in Mexico and South Africa.
